Search research articles
Contact Us
Filters
Showing results (141-150 of 298) with videos related to
Page
of 30
Sort By:
Journal of Addiction Medicine
|
January 8, 2014
Common bile duct dilatation in drug users with chronic hepatitis C is associated with current methadone use
Stije J Leopold, Bart P X Grady, Catharina E A Lindenburg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 9, 2022
Symptom patterns in the daily life of PSC patients
Kim N van Munster, Marcel G W Dijkgraaf, Ronald P J Oude Elferink, et al.
Journal of Hepatology
|
March 15, 2012
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, et al.
Journal of Hepatology
|
May 15, 2021
Erratum to: "Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia" (J Hepatol 2021; 74: 428-441)
David C Trampert, Stan F J van de Graaf, Aldo Jongejan, et al.
Clinical Reviews in Allergy & Immunology
|
May 16, 2014
Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review
Luca Maroni, Stan F J van de Graaf, Simon D Hohenester, et al.
Anticancer Research
|
July 26, 2007
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism
Stefan Holdenrieder, Peter Eichhorn, Ulrich Beuers, et al.
Inflammatory Bowel Diseases
|
April 26, 2013
Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma
Margriet R Timmer, Ulrich Beuers, Paul Fockens, et al.
Journal of Gastroenterology and Hepatology
|
May 3, 2014
Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis
Jimme K Wiggers, Anthony T Ruys, Bas Groot Koerkamp, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 21, 2014
[Risks of intrahepatic cholestasis of pregnancy]
A Ruth Bolier, Jiska M Jebbink, Joris A M van der Post, et al.
JHEP Reports : Innovation in Hepatology
|
April 26, 2021
Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases
Arun J Sanyal, Lei Ling, Ulrich Beuers, et al.
Page
of 30
Search research articles
Search
Showing results (141-150 of 298) with videos related to
Sort By:
Page
of 30
Journal of Addiction Medicine
|
January 8, 2014
Common bile duct dilatation in drug users with chronic hepatitis C is associated with current methadone use
Stije J Leopold, Bart P X Grady, Catharina E A Lindenburg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 9, 2022
Symptom patterns in the daily life of PSC patients
Kim N van Munster, Marcel G W Dijkgraaf, Ronald P J Oude Elferink, et al.
Journal of Hepatology
|
March 15, 2012
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, et al.
Journal of Hepatology
|
May 15, 2021
Erratum to: "Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia" (J Hepatol 2021; 74: 428-441)
David C Trampert, Stan F J van de Graaf, Aldo Jongejan, et al.
Clinical Reviews in Allergy & Immunology
|
May 16, 2014
Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review
Luca Maroni, Stan F J van de Graaf, Simon D Hohenester, et al.
Anticancer Research
|
July 26, 2007
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism
Stefan Holdenrieder, Peter Eichhorn, Ulrich Beuers, et al.
Inflammatory Bowel Diseases
|
April 26, 2013
Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma
Margriet R Timmer, Ulrich Beuers, Paul Fockens, et al.
Journal of Gastroenterology and Hepatology
|
May 3, 2014
Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis
Jimme K Wiggers, Anthony T Ruys, Bas Groot Koerkamp, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 21, 2014
[Risks of intrahepatic cholestasis of pregnancy]
A Ruth Bolier, Jiska M Jebbink, Joris A M van der Post, et al.
JHEP Reports : Innovation in Hepatology
|
April 26, 2021
Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases
Arun J Sanyal, Lei Ling, Ulrich Beuers, et al.
Page
of 30